• Jarret Cassaniti

    CCP | Program Officer
    HIV Basic Biology, Epidemiology, and Prevention

    When you watch, read, or listen to news about Ebola, does it bring to mind past health crises such as Spanish flu (occurred in 1918), smallpox (eradicated in 1980) or the current TB threat? More frequently, comparisons have appeared in the media to HIV/AIDS; I’ve noted how myths about Ebola are similar to those spread about HIV in the 1980s and 1990s. As the global public grapples with Ebola, the story of HIV is worth revisiting to see what new chapters have been written.

    HIV Basic Biology, Epidemiology, and Prevention contains revised sessions and new program experiences in areas of epidemiology, sexual dynamics, condoms, and behavioral prevention. Lead author Jim Shelton, USAID Science Advisor for the Bureau for Global Health, updated the course based on the latest research and programmatic evaluations.

  • Amanda BenDor

    PATH | Technical Program Manager

    Corinne Mahoney

    IntraHealth International | Senior Manager, Communications and Knowledge Management

    This blog post originally appeared on Vital, IntraHealth International's blog. 

    A year ago, who would have thought that Ebola would be a hot topic on World AIDS Day 2014?

    Today, the Ebola outbreak has spread to over 15,000 people, and Ebola and HIV have become unlikely bedfellows. The Ebola epidemic is not only disrupting HIV treatment for people who need it, it’s also reminding the global health community of the many missteps and lessons we learned during the early response to HIV. 

    “In the 30 years I've been working in public health, the only thing like [this Ebola outbreak] has been AIDS,” said director of the US Centers for Disease Control and Prevention Tom Frieden in October. “We have to work now so this is not the world’s next AIDS.”

    "One virus is a marathoner, the other a sprinter."

    One virus is a marathoner, the other a sprinter. AIDS has claimed more than 39 million lives since the epidemic began in the early 1980s. This Ebola outbreak has claimed over 5,400 in less than a year. But both have generated fear, stigma, and dangerous misinformation.

  • Rebecca Shore

    CCP | Program Officer II
    World AIDS Day Poster 2014

    This year’s World AIDS Day theme is “Focus, Partner, Achieve: An AIDS-Free Generation.” This seems fitting, as Apple recently announced a campaign to donate money to The Global Fund to help fight HIV and AIDS. A number of large corporations are publicly announcing their contributions to global health campaigns. For example, Mark Zuckerberg, Facebook’s founder and CEO, recently donated $25 million to CDC’s foundation to fight Ebola.

    Public-private partnerships (PPP) continue to be a large and important aspect of international development. More and more donors are now requiring some level of collaboration with private companies for their development work. The key to these partnerships and collaborations is the concept of “mutual benefit.”

  • Rebecca Shore

    CCP | Program Officer II

    This post, by Kate Plourde originally appeared on the Interagency Youth Working Group Blog. It highlights the release of a new resource for adolescents living with HIV.

    Why adolescents? 

    In 2012, young people ages 15 to 24 accounted for an estimated 40 percent of new nonpediatric HIV infections worldwide. Furthermore, perinatal HIV transmission is a major cause for HIV infection, and given the success of pediatric antiretroviral therapy (ART), many more infants born with HIV are growing up into adolescents and young adults living with HIV. 
    While care and treatment programs for people living with HIV (PLHIV) can be found in every country, there is a gap in provision of ongoing, supportive counseling for adolescents living with HIV (ALHIV). Adolescence is often when young people begin having sex, which increases chances that adolescents living with HIV might pass the infection to partners who are HIV negative. Another concern is that girls living with HIV may become pregnant; if they do not know about or have access to services for preventing mother-to-child transmission, they can pass the infection to their babies. Given that adolescents are a large sub-group of those living with HIV, there is a need for tailored interventions and support systems that address adolescents’ unique vulnerabilities. 

  • K4Health Highlights

    Becca Simon

    (Formerly) CCP | Communications Director

    This post by Ward Cates and Laura Raney originally appeared on the Huffington Post. It highlights the K4Health Microbicides Toolkit, which houses the latest research and policy guidance for this powerful and promising HIV prevention method. 

    The term "microbicide" was coined to define a variety of products such as gels, creams, films or suppositories that, when inserted into the vagina or rectum prior to sexual intercourse, might prevent HIV transmission during intercourse. This concept was initially developed specifically as a female-controlled method (vaginal application) to prevent sexual transmission through heterosexual intercourse. As a result, the term has achieved a certain brand recognition as a method primarily intended for use by women. However, safe and effective compounds can also serve as an important prevention tool for men who have sex with men (rectal application).